• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险在向医疗服务提供者支付费用方面面临的挑战。

Medicare's challenges in paying providers.

作者信息

Newhouse Joseph P

机构信息

Harvard University, Boston, MA 02115, USA.

出版信息

Health Care Financ Rev. 2005;27(2):35-44.

PMID:17290635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4194926/
Abstract

Medicare uses a variety of administered price systems to pay health care providers. In setting the amounts it pays, it faces significant challenges both to avoid distorting the care patients receive and not to overpay. This article describes issues in paying physicians, post-acute care providers, and health plans, all areas of recent ferment that are likely to see continued change. The conclusion remarks on the prescription drug benefit and the possibility of paying higher quality providers additional amounts.

摘要

医疗保险采用多种定价系统来向医疗服务提供者支付费用。在确定支付金额时,它面临着重大挑战,既要避免扭曲患者接受的治疗,又不能过度支付。本文描述了在向医生、急性后期护理提供者和健康计划支付费用方面存在的问题,所有这些领域最近都处于动荡之中,很可能会持续发生变化。结论部分评论了处方药福利以及向质量更高的提供者支付额外费用的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681e/4194926/cae7f9a32309/hcfr-27-2-035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681e/4194926/cae7f9a32309/hcfr-27-2-035-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/681e/4194926/cae7f9a32309/hcfr-27-2-035-g001.jpg

相似文献

1
Medicare's challenges in paying providers.医疗保险在向医疗服务提供者支付费用方面面临的挑战。
Health Care Financ Rev. 2005;27(2):35-44.
2
Medicare's post-acute care payment: a review of the issues and policy proposals.医疗保险的急性后期护理支付:问题与政策建议综述
Issue Brief George Wash Univ Natl Health Policy Forum. 2012 Dec 7(847):1-23.
3
Re-naming and re-gaming: Medicare's doomed attempt to reform reimbursement for injectable drugs.重新命名与重新博弈:医疗保险改革注射用药物报销的注定失败的尝试。
Health Aff (Millwood). 2004 Jul-Dec;Suppl Web Exclusives:W4-561-71. doi: 10.1377/hlthaff.w4.561.
4
Paying for value: replacing Medicare's sustainable growth rate formula with incentives to improve care.为价值付费:用激励措施取代医疗保险的可持续增长率公式以改善医疗服务。
Issue Brief (Commonw Fund). 2013 Mar;16:1-10.
5
Medicare payment options for recombinant erythropoietin therapy.重组促红细胞生成素治疗的医疗保险支付选项。
Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):93-7.
6
Medicare's two systems for paying providers.医疗保险支付医疗服务提供者的两种体系。
Health Aff (Millwood). 1988 Summer;7(3):120-32. doi: 10.1377/hlthaff.7.3.120.
7
The impact of Medicare reimbursement changes on home healthcare: a nursing perspective.医疗保险报销政策变化对家庭医疗保健的影响:护理视角
Home Healthc Nurse. 2000 Feb;18(2):116-22; quiz 122-3. doi: 10.1097/00004045-200002000-00011.
8
Medicare's Bundled Payment Initiatives for Hospital-Initiated Episodes: Evidence and Evolution.医疗保险对医院发起的疾病诊治整体支付计划:证据与演变。
Milbank Q. 2020 Sep;98(3):908-974. doi: 10.1111/1468-0009.12465. Epub 2020 Aug 21.
9
Key trends in Medicare payment policies. Understanding Medicare's long-term challenges is critical for executives.医疗保险支付政策的关键趋势。了解医疗保险的长期挑战对高管们至关重要。
Healthc Exec. 2006 May-Jun;21(3):44, 46.
10
Medicare's decision to withhold payment for hospital errors: the devil is in the det.医疗保险决定停止支付医院失误的费用:细节决定成败。 (你提供的原文最后一个单词“det”可能有误,推测应该是“details” )
Jt Comm J Qual Patient Saf. 2008 Feb;34(2):116-23. doi: 10.1016/s1553-7250(08)34014-8.

引用本文的文献

1
Trends in Medicare Reimbursement for Interventional Radiology Procedures: 2007-2020.2007 - 2020年医疗保险对介入放射学程序的报销趋势
Cureus. 2023 Aug 21;15(8):e43840. doi: 10.7759/cureus.43840. eCollection 2023 Aug.
2
Medicaid's role in the many markets for health care.医疗补助计划在众多医疗保健市场中的作用。
Health Care Financ Rev. 2007 Summer;28(4):69-82.

本文引用的文献

1
Adverse selection and the challenges to stand-alone prescription drug insurance.逆向选择与独立处方药保险面临的挑战。
Front Health Policy Res. 2004;7:55-74. doi: 10.2202/1558-9544.1051.
2
Surgical mortality as an indicator of hospital quality: the problem with small sample size.手术死亡率作为医院质量的指标:小样本量的问题。
JAMA. 2004 Aug 18;292(7):847-51. doi: 10.1001/jama.292.7.847.
3
How much should Medicare pay for drugs?医疗保险应该为药品支付多少钱?
Health Aff (Millwood). 2004 Jan-Feb;23(1):89-102. doi: 10.1377/hlthaff.23.1.89.
4
The quality of health care delivered to adults in the United States.美国为成年人提供的医疗保健质量。
N Engl J Med. 2003 Jun 26;348(26):2635-45. doi: 10.1056/NEJMsa022615.
5
The business case for quality: case studies and an analysis.质量的商业案例:案例研究与分析
Health Aff (Millwood). 2003 Mar-Apr;22(2):17-30. doi: 10.1377/hlthaff.22.2.17.
6
The Medicare prescription drug benefit: how will the game be played?医疗保险处方药福利:这场博弈将如何展开?
Health Aff (Millwood). 2000 Mar-Apr;19(2):8-23. doi: 10.1377/hlthaff.19.2.8.
7
The unreliability of individual physician "report cards" for assessing the costs and quality of care of a chronic disease.用于评估慢性病护理成本和质量的个体医生“成绩单”的不可靠性。
JAMA. 1999 Jun 9;281(22):2098-105. doi: 10.1001/jama.281.22.2098.
8
Resource-based relative values. An overview.基于资源的相对价值。概述。
JAMA. 1988 Oct 28;260(16):2347-53.